Table 3.
The number of drugs before and after medication reconciliation and observed medication discrepancies in the development and external validation cohorts.
|
|
Development (n=824) | Temporal validation (n=350) | Geographic validation (n=119) |
| Total number of drugs reported by the EDa physician, n | 5486 | 2266 | 734 |
| Number of drugs reported by the ED physician per patient, median (IQR) | 6 (3-10) | 5 (3-9) | 6 (3-9) |
| Total number of drugs after medication reconciliation | 6456 | 2614 | 926 |
| Number of drugs per patient after medication reconciliation, median (IQR) | 7 (4-11) | 7 (4-10) | 8 (4-10) |
| Total number of discrepancies, n | 1604 | 801 | 451 |
| Number of discrepancies per patient, median (IQR) | 1 (0-3) | 2 (1-3) | 3 (2-5) |
| Total number of clinically relevant discrepancies, n | 475 | 205 | 116 |
| Number of clinically relevant discrepancies per patient, median (IQR) | 0 (0-1) | 0 (0-1) | 1 (0-2) |
| At least 1 clinically relevant discrepancy (yes), n (%) | 287 (35) | 131 (37) | 58 (49) |
aED: emergency department.